Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) has landed a new supply agreement with the University of Virginia Health, which is upgrading to complete the transition to full clinical Xenon MRI capabilities.
The deal provides additional equipment for clinical use, following UVA’s upgrade of two hyperpolariser systems last year.
UVA Health was the site of the first human scan using hyperpolarised Xenon MRI in 1996. The institution has since developed applications across asthma, cystic fibrosis and other lung diseases, and was recently awarded a $7.4 million NIH grant to advance research.
"We are delighted to support UVA Health as they prepare to launch their first clinical Xenon MRI scan, anticipated to occur later this year," said chief executive Christopher von Jako
"Their deep and sustained commitment to advancing pulmonary imaging - from early research breakthroughs to today's clinical transition - perfectly aligns with Polarean's mission to provide critical imaging solutions for chronic lung disease.
He added: "UVA Health's decades-long leadership in Xenon MRI has been instrumental in shaping the field, and we look forward to continuing our partnership to improve lung health for patients everywhere."